Taylor & Francis-published open-access journal titled Bioengineered saw a major wave of retractions, with 118 retraction notices in October 2026. Clarivate removed the journal from its Web of Science Core Collection in 2025.
Taylor & Francis also acknowledged that the journal’s editorial integrity had been compromised between 2021 and 2022.
The retractions cover research papers published mainly in 2021 and 2022. These retracted papers addressed topics such as cancer biology, microRNA, genetics, cardiovascular diseases, molecular biology, and pharmaceutical research.
The large number of retractions comes amid an ongoing investigation by Taylor & Francis.
Why Were the Bioengineered Papers Retracted?
The retraction notices identify several concerns involving the integrity and reliability of the published research.
The reasons recorded across the notices include:
- Concerns or issues about research data
- Concerns about reported results and conclusions
- Missing or unavailable original data and images
- Image duplication or manipulation
- Plagiarism of images or data
- Authorship and affiliation concerns
- Investigations conducted by the journal, publisher, or third parties
- Authors who did not respond to requests for explanations
Bioengineered Journal Metrics
Despite its research-integrity problems and Web of Science delisting, the journal’s publisher website continues to display several citation and usage metrics.
| Metric | Details |
|---|---|
| Journal | Bioengineered |
| Publisher | Taylor & Francis |
| Access | Fully Open Access |
| Annual Downloads/Views | 1.3 Million |
| 2025 CiteScore | 15.4 |
| CiteScore Best Quartile | Q1 |
| 2025 SNIP | 1.022 |
| 2025 SJR | 1.023 |
| Web of Science Status | Removed in 2025 |